Bolt Biotherapeutics, Inc. (BOLT)
5.00
-0.06
(-1.19%)
USD |
NASDAQ |
Nov 20, 10:47
Bolt Biotherapeutics Free Cash Flow : -24.80M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -24.80M |
| June 30, 2026 | -31.52M |
| March 31, 2026 | -34.58M |
| December 31, 2025 | -39.92M |
| September 30, 2025 | -47.20M |
| June 30, 2025 | -51.40M |
| March 31, 2025 | -57.94M |
| December 31, 2024 | -61.33M |
| September 30, 2024 | -61.17M |
| June 30, 2024 | -64.08M |
| March 31, 2024 | -63.08M |
| December 31, 2023 | -69.73M |
| September 30, 2023 | -73.60M |
| Date | Value |
|---|---|
| June 30, 2023 | -70.87M |
| March 31, 2023 | -76.94M |
| December 31, 2022 | -78.46M |
| September 30, 2022 | -78.68M |
| June 30, 2022 | -84.23M |
| March 31, 2022 | -67.71M |
| December 31, 2021 | -59.40M |
| September 30, 2021 | -54.84M |
| June 30, 2021 | -48.76M |
| March 31, 2021 | -57.18M |
| December 31, 2020 | -50.57M |
| September 30, 2020 | -43.11M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Caribou Biosciences, Inc. | -92.99M |
| Oncolytics Biotech, Inc. | -28.39M |
| Sangamo Therapeutics, Inc. | -90.46M |
| Sarepta Therapeutics, Inc. | 167.79M |
| Anixa Biosciences, Inc. | -7.376M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.078M |
| Cash from Investing (Quarterly) | 4.00M |
| Free Cash Flow Per Share (Quarterly) | -1.566 |
| Free Cash Flow to Equity (Quarterly) | -2.343M |
| Free Cash Flow to Firm (Quarterly) | -3.078M |
| Free Cash Flow Yield | -230.2% |